A detailed history of Chartwell Investment Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Chartwell Investment Partners, LLC holds 208,318 shares of ABT stock, worth $26.7 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
208,318
Previous 219,283 5.0%
Holding current value
$26.7 Million
Previous $22.8 Million 4.24%
% of portfolio
0.81%
Previous 0.8%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$100.07 - $118.13 $1.1 Million - $1.3 Million
-10,965 Reduced 5.0%
208,318 $23.8 Million
Q2 2024

Aug 08, 2024

BUY
$100.73 - $112.44 $2.26 Million - $2.53 Million
22,472 Added 11.42%
219,283 $22.8 Million
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $3.28 Million - $3.63 Million
29,979 Added 17.97%
196,811 $22.4 Million
Q4 2023

Feb 15, 2024

BUY
$90.19 - $110.4 $2.54 Million - $3.11 Million
28,131 Added 20.28%
166,832 $18.4 Million
Q3 2023

Nov 07, 2023

BUY
$95.53 - $114.62 $80,627 - $96,739
844 Added 0.61%
138,701 $13.4 Million
Q2 2023

Jul 25, 2023

BUY
$100.78 - $112.29 $640,356 - $713,490
6,354 Added 4.83%
137,857 $15 Million
Q1 2023

Apr 14, 2023

SELL
$96.86 - $114.01 $46,589 - $54,838
-481 Reduced 0.36%
131,503 $13.3 Million
Q4 2022

Feb 15, 2023

SELL
$95.06 - $111.52 $211,888 - $248,578
-2,229 Reduced 1.66%
131,984 $14.5 Million
Q3 2022

Oct 27, 2022

BUY
$96.76 - $112.03 $448,869 - $519,707
4,639 Added 3.58%
134,213 $13 Million
Q2 2022

Aug 01, 2022

SELL
$102.07 - $123.37 $1.55 Million - $1.88 Million
-15,209 Reduced 10.5%
129,574 $14.1 Million
Q1 2022

Apr 26, 2022

SELL
$114.02 - $139.04 $6.22 Million - $7.58 Million
-54,515 Reduced 27.35%
144,783 $17.1 Million
Q4 2021

Feb 15, 2022

SELL
$115.53 - $141.46 $722,062 - $884,125
-6,250 Reduced 3.04%
199,298 $28 Million
Q3 2021

Nov 16, 2021

SELL
$116.66 - $129.06 $124,942 - $138,223
-1,071 Reduced 0.52%
205,548 $24.3 Million
Q2 2021

Jul 19, 2021

SELL
$105.79 - $124.53 $1.27 Million - $1.5 Million
-12,009 Reduced 5.49%
206,619 $24 Million
Q1 2021

May 03, 2021

SELL
$108.84 - $128.23 $190,578 - $224,530
-1,751 Reduced 0.79%
218,628 $26.2 Million
Q4 2020

Feb 09, 2021

SELL
$105.0 - $114.42 $3.94 Million - $4.3 Million
-37,556 Reduced 14.56%
220,379 $24.1 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $434,740 - $527,959
-4,744 Reduced 1.81%
257,935 $28.1 Million
Q2 2020

Jul 29, 2020

BUY
$76.57 - $98.0 $334,457 - $428,064
4,368 Added 1.69%
262,679 $24 Million
Q1 2020

Apr 30, 2020

BUY
$62.82 - $91.86 $736,941 - $1.08 Million
11,731 Added 4.76%
258,311 $20.4 Million
Q4 2019

Jan 29, 2020

BUY
$78.51 - $87.4 $893,600 - $994,786
11,382 Added 4.84%
246,580 $21.4 Million
Q3 2019

Oct 29, 2019

SELL
$81.84 - $88.74 $105,900 - $114,829
-1,294 Reduced 0.55%
235,198 $19.7 Million
Q2 2019

Aug 19, 2019

BUY
$72.88 - $85.0 $1.56 Million - $1.82 Million
21,456 Added 9.98%
236,492 $19.9 Million
Q1 2019

Apr 11, 2019

BUY
$66.22 - $80.06 $2.22 Million - $2.68 Million
33,472 Added 18.44%
215,036 $17.2 Million
Q4 2018

Feb 01, 2019

SELL
$65.56 - $74.27 $548,868 - $621,788
-8,372 Reduced 4.41%
181,564 $13.1 Million
Q3 2018

Nov 08, 2018

BUY
$60.81 - $73.36 $9,668 - $11,664
159 Added 0.08%
189,936 $13.9 Million
Q2 2018

Aug 09, 2018

BUY
$57.57 - $63.54 $2.33 Million - $2.57 Million
40,402 Added 27.05%
189,777 $11.6 Million
Q1 2018

May 08, 2018

SELL
$56.27 - $63.62 $218,046 - $246,527
-3,875 Reduced 2.53%
149,375 $8.53 Million
Q1 2018

May 08, 2018

BUY
$56.27 - $63.62 $218,046 - $246,527
3,875 Added 2.59%
153,250 $9.18 Million
Q4 2017

Feb 08, 2018

SELL
$53.68 - $57.47 $1.4 Million - $1.5 Million
-26,065 Reduced 14.86%
149,375 $8.53 Million
Q3 2017

Nov 08, 2017

BUY
$48.06 - $53.64 $8.43 Million - $9.41 Million
175,440
175,440 $9.36 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.